Weiss Multi-Strategy Advisers’s TG Therapeutics TGTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60,000	Closed	-$1.02M	–	435
2023 Q4	$1.02M	Buy	60,000 +17,637	+42%	+$205K	0.02%	430
2023 Q3	$354K	Buy	+42,363	New	+$591K	0.01%	496
2022 Q1	–	Sell	-12,666	Closed	-$241K	–	789
2021 Q4	$241K	Sell	12,666 -50	-0.4%	-$1.3K	0.01%	600
2021 Q3	$423K	Buy	+12,716	New	+$393K	0.01%	578
2017 Q1	–	Sell	-30,000	Closed	-$140K	–	625
2016 Q4	$140K	Hold	30,000	–	–	0.01%	390
2016 Q3	$232K	Sell	30,000 -600	-2%	-$3.86K	0.01%	390
2016 Q2	$185K	Sell	30,600 -20,400	-40%	-$166K	0.01%	380
2016 Q1	$435K	Hold	51,000	–	–	0.02%	398
2015 Q4	$608K	Hold	51,000	–	–	0.04%	291
2015 Q3	$514K	Buy	51,000 +21,000	+70%	+$313K	0.02%	318
2015 Q2	$498K	Sell	30,000 -10,000	-25%	-$158K	0.02%	381
2015 Q1	$619K	Buy	40,000 +4,000	+11%	+$60.6K	0.03%	352
2014 Q4	$570K	Buy	36,000 +1,000	+3%	+$13K	0.02%	330
2014 Q3	$373K	Buy	35,000 +10,000	+40%	+$92.7K	0.01%	459
2014 Q2	$235K	Buy	+25,000	New	+$160K	0.01%	681

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TGTX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of TG Therapeutics (TGTX) in Q1 2024, closing a stake of 60,000 shares — an estimated $1.02M sold.

Weiss Multi-Strategy Advisers first reported a position in TGTX in Q2 2014 and held it in 15 quarters. The position peaked at $1.02M in Q4 2023. 243 funds tracked by Wall St. Rank hold TGTX as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining TG Therapeutics position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 60,000 TG Therapeutics shares in Q1 2024, an estimated $1.02M.
Weiss Multi-Strategy Advisers first reported a position in TG Therapeutics in Q2 2014 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's TG Therapeutics position peaked at $1.02M in Q4 2023.
243 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.